The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
From ion currents to genomic analysis: Recent advances in GABAA receptor research
Abstract
The γ‐aminobutyric acid type A (GABA A) receptor represents an elementary switching mechanism integral to the functioning of the central nervous system and a locus for the action of many mood‐and emotion‐altering agents such as benzodiazepines, barbiturates, steroids, and alcohol. Anxiety, sleep disorders, and convulsive disorders have been effectively treated with therapeutic agents that enhance the action of GABA at the GABA A receptor or increase the concentration of GABA in nervous tissue. The GABA A receptor is a multimeric membrane‐spanning ligand‐gated ion channel that admits chloride upon binding of the neurotransmitter GABA and is modulated by many endogenous and therapeutically important agents. Since GABA is the major inhibitory neurotransmitter in the CNS, modulation of its response has profound implications for brain functioning. The GABA A receptor is virtually the only site of action for the centrally acting benzodiazepines, the most widely prescribed of the anti‐anxiety medications. Increasing evidence points to an important role for GABA in epilepsy and various neuropsychiatric disorders. Recent advances in molecular biology and complementary information derived from pharmacology, biochemistry, electrophysiology, anatomy and cell biology, and behavior have led to a phenomenal growth in our understanding of the structure, function, regulation, and evolution of the GABA A receptor. Benzodiazepines, barbiturates, steroids, polyvalent cations, and ethanol act as positive or negative modulators of receptor function. The description of a receptor gene superfamily comprising the subunits of the GABA A, nicotinic acetylcholine, and glycine receptors has led to a new way of thinking about gene expression and receptor assembly in the nervous system. Seventeen genetically distinct subunit subtypes (αl‐α6, βl‐β4, γl‐γ4,δ, pl‐p2) and alternatively spliced variants contribute to the molecular architecture of the GABA A receptor. Mysteriously, certain preferred combinations of subunits, most notably the αlβ2γ2 arrangement, are widely codistributed, while the expression of other subunits, such as βl or α6, is severely restricted to specific neurons in the hippocampal formation or cerebellar cortex. Nervous tissue has the capacity to exert control over receptor number, allosteric uncoupling, subunit mRNA levels, and posttranslational modifications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family
Schofield, P. R., Darlison, M. G., Fujita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., et al. (1987) · Nature · doi:10.1038/328221a0 · Cited by 1,622
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Benzodiazepine receptors in rat brain
SQUIRES, R. F., & BRAESTRUP, C. (1977) · Nature · doi:10.1038/266732a0 · Cited by 1,449
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,319
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., & Seeburg, P. H. (1989) · Nature · doi:10.1038/338582a0 · Cited by 1,293
Bormann, J., Hamill, O. P., & Sakmann, B. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016493 · Cited by 1,157
Laurie, D., Wisden, W., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04151.1992 · Cited by 1,143
Cited by
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
Benes, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00225-1 · Cited by 1,082
Structure, Function, and Modulation of GABAA Receptors
Sigel, E., & Steinmann, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.386664 · Cited by 812
Crystal structure of a human GABAA receptor
Miller, P. S., & Aricescu, A. R. (2014) · Nature · doi:10.1038/nature13293 · Cited by 710
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
GABA and GABA Receptors in the Central Nervous System and Other Organs
Watanabe, M., Maemura, K., Kanbara, K., Tamayama, T., & Hayasaki, H. (2002) · International Review of Cytology · doi:10.1016/s0074-7696(02)13011-7 · Cited by 630
Synaptic Control of Motoneuronal Excitability
Rekling, J. C., Funk, G. D., Bayliss, D. A., Dong, X.-W., & Feldman, J. L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.2.767 · Cited by 607
The benzodiazepine binding site of GABAA receptors
Sigel, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01118-8 · Cited by 594
Neurobiological Mechanisms of the Onset of Puberty in Primates*
Terasawa, E., & Fernandez, D. L. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0418 · Cited by 564
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Priestley, C. M., Williamson, E. M., Wafford, K. A., & Sattelle, D. B. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705542 · Cited by 501
Hevers, W., & Lüddens, H. (1998) · Molecular Neurobiology · doi:10.1007/bf02741459 · Cited by 489
Inhibitory neurotransmission, plasticity and aging in the mammalian central auditory system
Caspary, D. M., Ling, L., Turner, J. G., & Hughes, L. F. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.013581 · Cited by 481
Drug interactions at GABAA receptors
Korpi, E. R., Gründer, G., & Lüddens, H. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00013-8 · Cited by 473
Constructing inhibitory synapses
Moss, S. J., & Smart, T. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067500 · Cited by 466
Kapur, J., & Macdonald, R. L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07532.1997 · Cited by 427
General anaesthetic actions on ligand-gated ion channels
Krasowski, M. D., & Harrison, N. L. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050371 · Cited by 384
Park-Chung, M., Malayev, A., Purdy, R. H., Gibbs, T. T., & Farb, D. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01381-5 · Cited by 352
Self-citationGABA-Activated Ligand Gated Ion Channels: Medicinal Chemistry and Molecular Biology
Chebib, M., & Johnston, G. A. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9904349 · Cited by 345
Rigo, J., Hans, G., Nguyen, L., Rocher, V, Belachew, S., Malgrange, B., Leprince, P., Moonen, G., Selak, I., Matagne, A., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704766 · Cited by 336
Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322
Ion Channels in Sperm Physiology
Darszon, A., Labarca, P., Nishigaki, T., & Espinosa, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.481 · Cited by 321
Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor
Krause, R. M., Buisson, B., Bertrand, S., Corringer, P.-J., Galzi, J.-L., Changeux, J.-P., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.283 · Cited by 320
Kittler, J. T., Delmas, P., Jovanovic, J. N., Brown, D. A., Smart, T. G., & Moss, S. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-07972.2000 · Cited by 314
γ-Aminobutyric acid (GABA) signalling in plants
Ramesh, S. A., Tyerman, S. D., Gilliham, M., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2415-7 · Cited by 313
3 Regulation of ligand-gated ion channels by protein phosphorylation
Swope, S. L., Moss, S. J., Raymond, L. A., & Huganir, R. L. (1999) · Advances in Second Messenger and Phosphoprotein Research · doi:10.1016/s1040-7952(99)80005-6 · Cited by 296
The benzodiazepine binding site of GABAA receptors
Sigel, E., & Buhr, A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90675-1 · Cited by 290
The mechanisms of action of commonly used antiepileptic drugs
Kwan, P., Sills, G. J., & Brodie, M. J. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00122-x · Cited by 289
Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient Mice
Prosser, H. M., Gill, C. H., Hirst, W. D., Grau, E., Robbins, M., Calver, A., Soffin, E. M., Farmer, C. E., Lanneau, C., Gray, J., et al. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.0995 · Cited by 281
Jovanovic, J. N., Thomas, P., Kittler, J. T., Smart, T. G., & Moss, S. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3606-03.2004 · Cited by 273
Ethanol and neurotransmitter interactions—from molecular to integrative effects
Faingold, C. L., N'Gouemo, P., & Riaz, A. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00027-6 · Cited by 265
Forced Subunit Assembly in α1β2γ2 GABAAReceptors
Baumann, S. W., Baur, R., & Sigel, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207663200 · Cited by 260
Zinc-mediated inhibition of GABAA receptors: discrete binding sites underlie subtype specificity
Hosie, A. M., Dunne, E. L., Harvey, R. J., & Smart, T. G. (2003) · Nature Neuroscience · doi:10.1038/nn1030 · Cited by 256
Update on the Mechanism of Action of Antiepileptic Drugs
Meldrum, B. S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06038.x · Cited by 247
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Neurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Changing Properties of GABAAReceptor–Mediated Signaling During Early Neocortical Development
Owens, D. F., Liu, X., & Kriegstein, A. R. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.2.570 · Cited by 182
Wang, S., Cheng, Q., Malik, S., & Yang, J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35318-2 · Cited by 141
Pharmacological and Physiological Characterization of Murine Homomeric β3 GABAA Receptors
Wooltorton, J. R. A., Moss, S. J., & Smart, T. G. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01641.x · Cited by 129
Brandon, N. J., Jovanovic, J. N., Smart, T. G., & Moss, S. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06353.2002 · Cited by 106
Chapter 2 Hypothalamic Neural Systems Controlling the Female Reproductive Life Cycle
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(08)02002-9 · Cited by 93
Treatment of premenstrual dysphoric disorder
Rapkin, A. J., & Lewis, E. I. (2013) · Women s Health · doi:10.2217/whe.13.62 · Cited by 78
Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA α5-selective inverse agonists
Martínez-Cué, C., Delatour, B., & Potier, M.-C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.008 · Cited by 58
Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
Farb, D. H., & Ratner, M. H. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009126 · Cited by 55
Self-citationTakahashi, A., Kwa, C., DeBold, J. F., & Miczek, K. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1920-x · Cited by 52
NMDA-NR1 and -NR2B subunits mRNA expression in the hippocampus of rats tolerant to Diazepam
Pérez, M. F., Salmirón, R., & Ramı́rez, O. A. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00072-x · Cited by 19
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
Berezhnoy, D., Gravielle, M. C., Downing, S., Kostakis, E., Basile, A. S., Skolnick, P., Gibbs, T. T., & Farb, D. H. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-11 · Cited by 18
Self-citationPolycomblike protein PHF1b: a transcriptional sensor for GABA receptor activity
Saha, S., Hu, Y., Martin, S. C., Bandyopadhyay, S., Russek, S. J., & Farb, D. H. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-37 · Cited by 9
Self-citation
Metadata
- Authors
- Rabow, L. E., Russek, S. J., & Farb, D. H.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 21
- Issue
- 3
- Pages
- 189-274
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2004010919
- Cited by
- 475
- References
- 464
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.